Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Predictive Biomarkers of Secondary Aggravation in Covid-19 Suspect Patient Admitted to Emergency Departments During an Epidemic

NCT04341792 is registered in ClinicalTrials.gov with University Hospital, Lille as lead sponsor.

NCT NCT04341792
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04341792 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Predictive Biomarkers of Secondary Aggravation in Covid-19 Suspect Patient Admitted to Emergency Departments During an Epidemic
Lead sponsor
University Hospital, Lille
Phase
Observational
Overall status
Completed
Start date
April 11, 2020
Completion date
November 12, 2020
Enrollment
373 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

coronavirus, covid-19, infection viral